MICRONICS JAPAN CO.,LTD. FY2026 Q2 Earnings Report

Quick View

Executive Summary

Revenue and earnings increased substantially due to expanding demand for the Probe Card Business, highlighting a clearly operating-leveraged earnings structure. Revenue was ¥492.1B (+48.6% YoY), Operating Income was ¥155.6B (+105.5%), Ordinary Income was ¥162.6B (+119.9%), and Net Income was ¥114.6B (+140.1%). The Operating Income margin improved by 870bp to 31.6% from 22.9% in the same period of the previous year, demonstrating high-quality growth in which earnings growth significantly outpaced revenue growth.

Factors Affecting Performance

【Revenue】Revenue was ¥492.1B, up +48.6% YoY. While the Probe Card Business drove growth with revenue of ¥485.4B (+50.8% YoY, 98.7% of consolidated revenue), the TestEquipment Business contracted to ¥6.6B (-27.9% YoY).

【Profit and Loss】Operating Income was ¥155.6B (+105.5% YoY), with a gross margin of 51.0% and an SG&A expense ratio of 19.4%; effective control of fixed costs relative to revenue growth generated high operating leverage. Ordinary Income increased to ¥162.6B (+119.9% YoY) after adding ¥8.0B in non-operating income, primarily comprising ¥6.9B in foreign exchange gains. Pre-tax income reached ¥172.5B following the addition of ¥10.0B in subsidy income as extraordinary income, while Net Income reached ¥114.6B (+140.1% YoY). The key characteristic was that earnings growth significantly outpaced revenue growth amid increases in both revenue and earnings.

Segment Analysis

The Probe Card Business generated revenue of ¥485.4B (+50.8% YoY) and segment income of ¥182.9B (+94.1%), with its profit margin improving to 37.7% from 29.3% in the previous year, making it the core of consolidated earnings. The TestEquipment Business recorded revenue of ¥6.6B (-27.9% YoY), while its segment loss widened to ¥7.8B (loss of ¥2.7B in the previous year). After deducting ¥19.5B in corporate expenses, consolidated Operating Income was ¥155.6B, indicating an earnings structure that is highly dependent on the core business.

Key Financial Metrics

【Profitability】The Operating Income margin of 31.6% and Net Income margin of 23.3% both improved substantially from the same period of the previous year (22.9% and 14.7%, respectively), indicating progress in absorbing fixed costs through scale expansion.【Cash Flow Quality】ROE was 12.5%, and Operating Cash Flow (OCF) was ¥121.7B, or 1.06 times Net Income, indicating sound cash backing for accounting earnings; however, increases of ¥44.1B in trade receivables and ¥24.8B in inventories have created a working capital burden.【Investment Efficiency】Capital expenditures of ¥76.5B were 2.1 times depreciation of ¥36.0B, indicating a phase of capacity expansion, while Free Cash Flow remained positive at ¥46.6B.【Financial Soundness】With an Equity Ratio of 65.8%, cash and deposits of ¥200.5B, and interest-bearing debt limited to ¥64.4B, the Company is in a net cash position with high financial flexibility.

Cash Flow Analysis

Operating Cash Flow (OCF) increased substantially to ¥121.7B, up +172.5% YoY, and stood at 1.06 times Net Income of ¥114.6B, indicating sound support for accounting earnings. However, trade receivables increased by ¥44.1B and inventories by ¥24.8B, with the accumulation of working capital absorbing part of cash generation. Investing Cash Flow was -¥75.0B, including ¥76.5B in capital expenditures, as investment in production capacity expansion continued; investment was funded by OCF, securing positive Free Cash Flow of ¥46.6B. Financing Cash Flow was -¥37.7B, primarily reflecting outflows from dividend payments. As a result, cash and cash equivalents increased, maintaining liquidity while balancing active investment and shareholder returns.

Quality of Earnings

Non-operating income was limited to ¥8.0B against Operating Income of ¥155.6B, primarily comprising ¥6.9B in foreign exchange gains, indicating low dependence on recurring non-operating income. The ¥9.9B increase from Ordinary Income of ¥162.6B to pre-tax income of ¥172.5B was primarily attributable to ¥10.0B in subsidy income recognized as extraordinary income, which should be distinguished as a temporary factor. This subsidy represented 8.7% of Net Income of ¥114.6B; therefore, when evaluating Net Income growth of +140.1%, it is necessary to distinguish it from core Operating Income growth of +105.5%. OCF was 1.06 times Net Income, indicating good accrual quality, although the efficiency of cash conversion has declined somewhat due to increases in trade receivables and inventories.

Earnings Forecasts and Guidance

The full-year Company forecast is revenue of ¥1,038.0B (+47.9% YoY), Operating Income of ¥314.0B (+89.8%), and Ordinary Income of ¥320.0B (+87.1%), with revisions to the earnings forecast made during the current quarter. First-half progress rates were 47.4% for revenue, 49.5% for Operating Income, and 50.8% for Ordinary Income. With only a small deviation from the standard first-half progress rate of 50%, results are broadly consistent with the full-year plan. The Company’s plan assumes the continuation of the high earnings level achieved in the first half during the second half as well.

Shareholder Returns

Dividends for both Q1 and Q2 were ¥0, while the full-year dividend forecast is ¥178.0 per share, with a revision to the dividend forecast made during the current quarter. The forecast Payout Ratio against forecast full-year EPS of ¥593.31 is approximately 30.0%, which does not represent an excessive distribution burden relative to the earnings level. The net cash position, with cash and deposits of ¥200.5B and interest-bearing debt of ¥64.4B, together with first-half Free Cash Flow of ¥46.6B, provides financial support for continued dividend payments.

Risk Factors

1. Business portfolio concentration: The Probe Card Business accounts for 98.7% of consolidated revenue, resulting in high dependence on the capital investment cycle for semiconductor testing-related equipment. The TestEquipment Business recorded a revenue decline of -27.9% YoY, while its segment loss widened to ¥7.8B, with losses continuing.

2. Accumulation of working capital: Trade receivables increased by ¥44.1B and inventories by ¥24.8B, causing the efficiency of cash generation to decline relatively during the earnings growth phase. Work-in-process inventories amounted to ¥93.6B, accounting for 6割 of inventories, creating risks of stagnation in the production process and inventory valuation risks when demand fluctuates.

3. Impact of securities valuation: Investment securities amounted to ¥364.0B, accounting for 26.2% of total assets, and ¥176.7B of comprehensive income of ¥288.7B represented valuation differences on securities. The increase in net assets is materially sensitive not only to cash generation from the core business but also to fluctuations in market prices.

Industry Benchmark (Reference; Company Research)

Industry Benchmark (manufacturing)

Profitability and Returns

The Company’s profitability is substantially above the industry median and exceeds even the upper end of the range (IQR upper limit of 23.7%), representing a high level of profitability.

Growth and Capital Efficiency

The Company is growing at a pace well above the upper range of growth rates within the industry.

※Source: Company research

Key Points from the Earnings Results

1. The Operating Income margin of 31.6% and Net Income margin of 23.3% are substantially above the industry median. Operating leverage driven by expanding demand for the Probe Card Business and fixed-cost absorption is the central characteristic of the earnings results.

2. The first-half progress rate against the full-year Operating Income forecast was 49.5%, within the standard range, confirming consistency with the Company’s plan.

3. The somewhat lower cash conversion efficiency of OCF due to increases in trade receivables and inventories, as well as the widening loss in the TestEquipment Business, are items that should be monitored continuously in future earnings results.

Theoretical Share Price (Reference Value)

Sensitivity: ¥3,593–¥3,813 at ±1% for the cost of equity, and ¥3,664–¥3,756 at ±0.1 for ω.

Notes:

• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data. It is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmark is reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q2 was an exceptionally strong first half for Nippon Micronics, led by sharp volume and profitability expansion in the Probe Card business. Revenue rose 48.6% year on year to ¥49.21bn, while operating income more than doubled, increasing 105.5% to ¥15.56bn. Ordinary income increased 119.9% to ¥16.26bn and net income grew 140.0% to ¥11.46bn. The operating margin expanded to 31.6% from 22.9% a year earlier, an improvement of approximately 876 basis points. Gross margin improved to 51.0% from 49.5%, a 150-basis-point expansion, indicating that the earnings acceleration was driven by both improved product mix or pricing and operating leverage. Net margin rose to 23.3% from 14.4%, up about 890 basis points. The core Probe Card segment generated ¥48.54bn of sales, up 50.8%, and segment profit of ¥18.29bn, up 94.1%. Its segment margin remained very high at 37.7%, although it declined from 29.3% only in the sense that the base comparison? No, it expanded materially by approximately 844 basis points. The TE segment remained loss-making, with its loss widening to ¥0.79bn from ¥0.27bn despite lower revenue. Operating cash flow of ¥12.17bn exceeded net income of ¥11.46bn, producing an OCF/net-income ratio of 1.06x and supporting the reported profit quality. However, cash conversion measured as OCF/EBITDA was 0.64x, below the 0.7x alert threshold, primarily reflecting working-capital absorption and a ¥2.48bn inventory increase. Inventory quality requires attention: annualized DIO is 117 days and work in process represents 60.5% of inventory, indicating a potentially elongated production cycle or an accumulation of partly completed products. The company is investing aggressively, with H1 capital expenditure of ¥7.65bn and CapEx/depreciation of 2.13x, consistent with capacity expansion rather than maintenance-only spending. Free cash flow remained positive at ¥4.66bn despite this investment intensity. The full-year forecast implies revenue of ¥103.80bn, operating income of ¥31.40bn, and net income of ¥23.00bn; H1 progress is near the standard 50% level across earnings lines. Management has revised both earnings and dividend forecasts, making the sustainability of Probe Card demand, WIP normalization, and the return on incremental manufacturing investment the central issues for the second half.

Profitability Analysis

Annualized DuPont ROE is 25.1%, comprising a 23.3% net profit margin, 0.709x asset turnover, and 1.52x financial leverage. The main contributor to high ROE is profitability rather than aggressive balance-sheet leverage: net margin is exceptionally high and financial leverage is moderate. The largest year-on-year change was the expansion in operating profitability, as operating income rose 105.5%, far faster than revenue growth of 48.6%. Gross margin expanded 150 basis points to 51.0%, while operating margin expanded approximately 876 basis points to 31.6%; this indicates substantial operating leverage as revenue growth outpaced SG&A growth. SG&A increased only 8.2% year on year to ¥9.56bn, versus 48.6% revenue growth, reducing the SG&A-to-sales ratio to 19.4% from 26.7%. EBITDA was ¥19.16bn and the EBITDA margin was 38.9%, underlining strong cash earnings before the current expansionary investment program. The five-factor analysis shows a tax burden of 0.664 and an interest burden of 1.109; the latter reflects non-operating income exceeding finance costs rather than debt dependence. Foreign-exchange gains of ¥0.69bn supported ordinary income, but represent only 4.5% of operating income and do not alter the conclusion that operating earnings were the primary driver. Profit before tax also included a ¥1.00bn extraordinary subsidy, which lifted net income but is not part of recurring operating profitability. Excluding that subsidy, profitability would still be materially above the prior-year level. The Probe Card business is clearly the core business, contributing essentially all segment revenue and more than all reportable-segment profit, given TE losses. Probe Card revenue rose from ¥32.20bn to ¥48.54bn and segment profit from ¥9.42bn to ¥18.29bn, producing a 37.7% segment margin versus 29.3% a year earlier. TE revenue declined from ¥0.92bn to ¥0.66bn, while its segment loss widened from ¥0.27bn to ¥0.79bn; its negative margin deteriorated to 118.2%. The very high Probe Card margin is likely sustainable only insofar as advanced semiconductor test demand, utilization, yields, and product mix remain favorable; the current earnings base should therefore be monitored for cycle sensitivity.

Growth Assessment

Revenue growth of 48.6% was concentrated in Probe Cards, where sales increased 50.8% year on year. This concentration makes the growth profile highly exposed to semiconductor capital-spending and advanced-device test demand, but the scale of segment profit growth confirms strong operating execution in the first half. The company converted ¥49.21bn of H1 revenue into ¥15.56bn of operating income, demonstrating unusually strong incremental margins. The full-year revenue forecast of ¥103.80bn implies H1 progress of 47.4%, modestly below the standard 50% H1 run rate but well within a normal seasonal range. Operating-income progress is 49.5%, ordinary-income progress is 50.8%, and net-income progress is 49.8%, all broadly consistent with the full-year plan. Consequently, reported guidance does not require an outsized second-half earnings acceleration. The full-year forecast calls for 47.9% revenue growth and 89.8% operating-income growth, broadly aligned with first-half momentum, although the forecast implies some moderation in revenue growth relative to H1. Capacity investment is material: annualized from the reported H1 flow, capital expenditure is running at roughly ¥15.30bn, or about 15.5% of H1-annualized revenue. This investment may support future shipment growth and technology capability, but also raises the importance of demand visibility and utilization. The increase in WIP and high annualized inventory days suggest that production is being positioned for demand or is taking longer to convert into shipments. Future growth quality will be stronger if WIP converts into revenue and operating cash flow without additional inventory-day deterioration. The TE business remains a drag on consolidated growth and profitability, so recovery in its revenue and loss profile would improve diversification and reduce reliance on Probe Cards.

Financial Health

Liquidity is strong, with a current ratio of 178.2%, a quick ratio of 178.2%, and working capital of ¥23.69bn. Cash and deposits of ¥20.05bn substantially exceed short-term loans of ¥0.36bn, equivalent to cash/short-term debt of 56.0x. This indicates no evident short-term maturity mismatch between current assets and near-term borrowings. Interest-bearing debt totals ¥6.44bn, consisting primarily of ¥6.09bn in long-term loans, while short-term debt accounts for only 5.6% of debt. Debt/EBITDA is a conservative 0.34x, debt/capital is 6.6%, and EBITDA interest coverage is 242.47x; debt servicing capacity is therefore very strong. Total equity increased to ¥91.32bn from ¥66.05bn, supported by first-half earnings and a substantial increase in valuation and translation adjustments. Investment securities rose ¥25.74bn year on year, or 241.5%, to ¥36.40bn and represent 26.2% of total assets. The increase was accompanied by a ¥17.67bn valuation gain recognized in OCI during the period, making reported equity and comprehensive income meaningfully exposed to market-value fluctuations in the securities portfolio. Accounts receivable increased ¥4.42bn, or 38.8%, to ¥15.84bn, broadly below revenue growth but still requiring monitoring alongside inventory build. Accounts payable rose ¥2.07bn, or 27.6%, to ¥9.57bn, partially funding working-capital growth. Short-term loans declined 46.5% to ¥0.36bn, further reducing near-term refinancing exposure. PPE of ¥43.57bn represents 31.4% of total assets, consistent with a manufacturing model and current capacity expansion. Intangible assets are only 0.8% of assets, limiting balance-sheet dependence on acquired intangibles. Defined-benefit liabilities of ¥1.97bn and bonus provisions of ¥3.39bn are recognized liabilities that should be incorporated into ongoing fixed-cost and cash-planning assessments.

Notable B/S Changes

Investment securities: +¥25.74bn (+241.5%) to ¥36.40bn, representing 26.2% of total assets; the associated valuation gains materially increased OCI and create market-value sensitivity in equity. Accounts receivable: +¥4.42bn (+38.8%) to ¥15.84bn; growth was below revenue growth but contributed to working-capital absorption and should be monitored for collection conversion. Accounts payable: +¥2.07bn (+27.6%) to ¥9.57bn; higher supplier balances partly funded the inventory and receivables build, though payable growth lagged operating-scale growth. Short-term loans: -¥0.31bn (-46.5%) to ¥0.36bn; the reduction further limits short-term refinancing risk. Total equity: +¥25.27bn (+38.3%) to ¥91.32bn; the increase reflects strong earnings and large valuation-related OCI, so part of the capital expansion is market-sensitive rather than cash generated.

Cash Flow Quality

Operating cash flow was ¥12.17bn, exceeding net income of ¥11.46bn and yielding an OCF/net-income ratio of 1.06x. This is a favorable earnings-quality indicator, and the accruals ratio of negative 0.5% also indicates that reported earnings were not reliant on aggressive accrual creation. Operating cash flow increased sharply from ¥4.47bn in the prior-year period, broadly tracking the improvement in operating profit. Nevertheless, the quality alert for low cash conversion is valid: OCF/EBITDA was 0.64x, below the 0.7x threshold. The root cause is a combination of investment in working capital, including a ¥4.41bn increase in trade receivables and a ¥2.48bn inventory increase, which was only partly offset by a ¥2.33bn increase in trade payables. Inventory composition is a material manufacturing-specific concern. Raw materials were ¥4.96bn, WIP was ¥9.36bn, and finished goods were ¥1.14bn. Annualized inventory days of 117 exceed the 90-day warning level, while WIP's 60.5% share of inventory exceeds the 40% warning benchmark. This pattern may reflect capacity ramp-up, complex production lead times, or production bottlenecks; it raises the risk of cash being tied up longer than implied by the income statement. Product-warranty provisions declined by ¥0.42bn in operating cash flow, which provided a cash-flow benefit, while the ending warranty provision remained ¥1.18bn. Investing cash flow was negative ¥7.51bn, almost entirely due to ¥7.65bn of capital expenditure, partially offset by ¥0.40bn of subsidies received. Free cash flow was positive ¥4.66bn, demonstrating that current operating earnings can fund a substantial portion of expansion investment. Financing cash flow was negative ¥3.77bn, principally reflecting ¥3.68bn of cash dividends paid and ¥0.18bn of long-term debt repayment. Cash increased ¥0.82bn during the first half despite the capital program and shareholder distributions. The key confirmation for cash-flow quality in the second half will be whether WIP and receivables convert into cash while capital expenditure remains disciplined.

Dividend Sustainability

No Q1 or Q2 dividend was paid, while the revised full-year forecast calls for DPS of ¥178. Based on forecast EPS of ¥593.31, the implied dividend payout ratio is approximately 30.0%. This is comfortably below the 60% sustainability benchmark and leaves substantial earnings retention for capacity investment and balance-sheet resilience. Applying the forecast DPS to average shares outstanding implies an indicative full-year dividend cash requirement of roughly ¥6.90bn. H1 free cash flow was ¥4.66bn, which does not independently cover that full-year dividend amount, but H1 cash flow includes a high level of growth capital expenditure and is only a half-year figure. The company has ¥20.05bn of cash and deposits, low debt, and robust operating profitability, providing ample liquidity support for the planned dividend. Financing cash flow included ¥3.68bn of dividends paid during H1, showing that shareholder distributions are already a meaningful use of cash. Dividend sustainability is therefore supported by forecast earnings, net cash capacity, and conservative leverage rather than by first-half free cash flow alone. A sustained deterioration in semiconductor demand, inventory conversion, or capital-expenditure requirements would be the principal risks to future distribution flexibility.

Risk Assessment

Business risks include Semiconductor-cycle concentration: the Probe Card business accounts for nearly all revenue and more than all reportable-segment profit, making consolidated earnings highly sensitive to customer capital expenditure, device transitions, and test-demand cycles., Production and inventory risk: annualized DIO of 117 days and WIP at 60.5% of inventory indicate an extended manufacturing cycle. The root cause may be production ramp-up or bottlenecks; the impact is greater risk of delayed cash conversion, inventory obsolescence, and margin pressure if demand weakens., TE business deterioration: TE revenue declined 27.9% year on year and its segment loss widened to ¥0.79bn. Continued losses dilute group profitability and reduce business diversification., Foreign-exchange exposure: FX gains of ¥0.69bn supported ordinary income. Although not material relative to operating income, a reversal in currency conditions could reduce non-operating earnings., Manufacturing execution risk: the CapEx/depreciation ratio of 2.13x indicates a substantial expansion program. Delays in ramp-up, lower utilization, yield issues, or customer qualification delays could weaken returns on this investment..

Financial risks include Securities valuation exposure: investment securities increased to ¥36.40bn, or 26.2% of total assets, and OCI included a ¥17.67bn valuation gain. Market declines could materially reduce comprehensive income and equity., Cash conversion risk: OCF/EBITDA of 0.64x is below the 0.7x threshold. While OCF exceeded net income, continued receivables and inventory growth could reduce free-cash-flow conversion., Capital-allocation risk: H1 CapEx of ¥7.65bn exceeded depreciation by 2.13x. The investment program is affordable under current conditions, but requires sustained high demand to earn an adequate return..

Key concerns include Highest priority: normalization of inventory days and WIP conversion into shipments and cash., Highest priority: durability of Probe Card demand and margins after an exceptional first-half expansion., Medium priority: recovery plan and loss containment in the TE segment., Medium priority: volatility in the large investment-securities portfolio and its effect on equity., Lower priority: refinancing and interest-rate risk, given debt/EBITDA of 0.34x, debt/capital of 6.6%, and EBITDA interest coverage of 242.47x..

Investment Implications

Key takeaways include H1 operating performance was outstanding: revenue increased 48.6%, operating income increased 105.5%, and operating margin reached 31.6%., Profitability is driven primarily by a high 23.3% net margin and strong operating leverage, not by financial leverage., The Probe Card segment is the earnings engine, with ¥48.54bn revenue and a 37.7% segment margin., Operating cash flow exceeded net income and free cash flow remained positive despite aggressive capacity investment., High inventory days and WIP concentration are the most important operating-quality issues to monitor., The balance sheet is financially robust, but the enlarged investment-securities portfolio adds material OCI and equity-market sensitivity., The revised full-year guidance is broadly supported by H1 progress rates near 50%, rather than requiring a pronounced second-half step-up..

Metrics to watch include Probe Card segment revenue growth and segment margin, TE segment revenue and operating-loss trajectory, Annualized inventory days, WIP share, and inventory write-down indicators, Receivables growth relative to revenue and operating cash flow, OCF/EBITDA cash conversion and free cash flow after capital expenditure, CapEx level, depreciation growth, and utilization of newly expanded capacity, Investment-securities valuation changes and OCI volatility, Progress against full-year revenue of ¥103.80bn, operating income of ¥31.40bn, and net income of ¥23.00bn.

Regarding relative positioning, The company exhibits profitability metrics that are substantially above standard manufacturing benchmarks, including a 31.6% operating margin, 23.3% net margin, 25.1% annualized ROE, and 38.9% EBITDA margin. Its leverage and liquidity profile are conservative, with low debt relative to EBITDA and very high interest coverage. Relative positioning is therefore characterized by high-margin semiconductor-test exposure paired with elevated cyclicality and working-capital execution risk, rather than by balance-sheet stress.